Hiroki Takahata
University of Toyama
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Hiroki Takahata.
Proceedings of the National Academy of Sciences of the United States of America | 2001
Erbo Dong; Kinzo Matsumoto; Veska Uzunova; Ikuko Sugaya; Hiroki Takahata; Hiroaki Nomura; Hiroshi Watanabe; Erminio Costa; Alessandro Guidotti
Allopregnanolone (ALLO), is a brain endogenous neurosteroid that binds with high affinity to γ-aminobutyric acid type A (GABAA) receptors and positively modulates the action of GABA at these receptors. Unlike ALLO, 5α-dihydroprogesterone (5α-DHP) binds with high affinity to intracellular progesterone receptors that regulate DNA transcription. To investigate the physiological roles of ALLO and 5α-DHP synthesized in brain, we have adopted a mouse model involving protracted social isolation. In the frontal cortex of mice, socially isolated for 6 weeks, both neurosteroids were decreased by approximately 50%. After administration of (17β)-17-(bis-1-methyl amino carbonyl) androstane-3,5-diene-3-carboxylic acid (SKF105,111), an inhibitor of the enzyme (5α-reductase Type I and II) that converts progesterone into 5α-DHP, the ALLO and 5α-DHP content of frontal cortex of both group-housed and socially isolated mice decreased exponentially to 10%–20% of control values in about 30 min. The fractional rate constants (k h−1) of ALLO and 5α-DHP decline multiplied by the ALLO and 5α-DHP concentrations at any given steady-state estimate the rate of synthesis required to maintain that steady state. After 6 weeks of social isolation, ALLO and 5α-DHP biosynthesis rates were decreased to 30% of the values calculated in group-housed mice. Moreover, in socially isolated mice, the expression of 5α-reductase Type I mRNA and protein was approximately 50% lower than in group-housed mice whereas 3α-hydroxysteroid oxidoreductase mRNA expression was equal in the two groups. Protracted social isolation in mice may provide a model to investigate whether 5α-DHP by a genomic action, and ALLO by a nongenomic mechanism down-regulate the action of drugs acting as agonists, partial agonists, or positive allosteric modulators of the benzodiazepine recognition sites expressed by GABAA receptors.
ChemInform | 1979
Hiroki Takahata; Torahiko Hashizume; Takao Yamazaki
Chemical & Pharmaceutical Bulletin | 1980
Hiroki Takahata; Minoru Ishikura; Takao Yamazaki
Chemical & Pharmaceutical Bulletin | 1980
Katsuhide Matoba; Toshio Imai; Yoshie Nishino; Hiroki Takahata; Yoshiro Hirai; Takao Yamazaki
Journal of Heterocyclic Chemistry | 1979
Takao Yamazaki; Hiroki Takahata; Tomoko Matsuura; Raymond N. Castle
Journal of Heterocyclic Chemistry | 1977
Takao Yamazaki; Masanori Nagata; Katsuhide Matoba; Hiroki Takahata; Raymond N. Castle
ChemInform | 1978
Takao Yamazaki; Hiroki Takahata; Minoru Ishikura; Masanori Nagata
International Symposium on the Chemistry of Natural Products | 1988
Hiroki Takahata; Tamotsu Takamatsu; Takao Yamazaki
ChemInform | 1986
Hiroki Takahata; Tomoko Nakajima; Masaharu Nakano; Akira Tomiguchi; Takao Yamazaki
ChemInform | 1985
Hiroki Takahata; Tomoko Nakajima; Katsuhide Matoba; Takao Yamazaki